CRL: Nomura reports 1.6% stake with 807,923 shares in 13G/A
Rhea-AI Filing Summary
Charles River Laboratories (CRL): Schedule 13G/A reports that Nomura Holdings, Inc. beneficially owns 807,923 shares of CRL common stock, equal to 1.6% of the class. The ownership is held with sole voting and dispositive power and is attributed to Nomura subsidiaries Nomura Global Financial Products, Inc., Nomura Securities International, Inc., and Nomura International PLC.
The percentage is based on 49,215,000 shares outstanding as of September 27, 2025. Nomura certifies the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Nomura disclose in its Schedule 13G/A for CRL?
Nomura Holdings, Inc. reported beneficial ownership of 807,923 CRL shares, representing 1.6% of the outstanding common stock.
How was the 1.6% ownership in CRL calculated?
It was calculated using 49,215,000 shares outstanding as of September 27, 2025, as reported by the issuer.
What certification did Nomura include about its CRL holdings?
Nomura certified the shares were acquired and are held in the ordinary course of business and not to influence control.
What is the date of the event requiring this filing?
The event date is September 30, 2025.